Compositions and methods for generating massively parallel nucleic acid sequencing libraries
AssigneeBioo Scientific Corporation
InventorsKevin D. Allen, Kerry Gunning
Life of this patent
Estimating the term…
Loading patent…
AssigneeBioo Scientific Corporation
InventorsKevin D. Allen, Kerry Gunning
Estimating the term…
Oligonucleotide primers and methods of use in producing sequencing libraries are provided according to aspects of the present disclosure which include, from 5′ to 3′, a homopolymer-hybridizing region, and an anchor region comprising 5′-(λ)nNm-3′, wherein the homopolymer-hybridizing region is a contiguous sequence of 5 to 20 elements, wherein the elements are nucleotides or Tm increasing nucleotide analogs, wherein at least 4 of the elements are Tm increasing nucleotide analogs, wherein the homopolymer-hybridizing region hybridizes to a complementary homopolymer tract of a target nucleic acid, wherein the complementary homopolymer tract comprises a contiguous sequence of complementary elements, wherein λ is any nucleotide or nucleotide analog with the proviso that λ is not a nucleotide or nucleotide analog complementary to a complementary element of the complementary homopolymer tract, and wherein N is any nucleotide or nucleotide analog.
An oligonucleotide primer, comprising, from 5′ to 3′, a homopolymer-hybridizing region, and an anchor region comprising 5′-(λ)nNm-3′, where n is an integer in the range of 1 to 20, and m is an integer in the range of 1 to 10, wherein the homopolymer-hybridizing region is a contiguous sequence of 5 to 20 elements, wherein the elements are nucleotides or Tm increasing nucleotide analogs, wherein at least 4 of the elements are Tm increasing nucleotide analogs, wherein the homopolymer-hybridizing region hybridizes to a complementary homopolymer tract of a target nucleic acid, wherein the complementary homopolymer tract comprises a contiguous sequence of complementary elements, wherein λ is any nucleotide or nucleotide analog with the proviso that λ is not a nucleotide or nucleotide analog complementary to a complementary element of the complementary homopolymer tract, and wherein N is any nucleotide or nucleotide analog.
Dependencies are inferred from the claim text.